Veering a little off topic from finance topics to policy and reimbursement, but I figure with all the smart folks on this forum, it is worth posting and discussing.
MACRA (Medicare Access and CHIP reauthorization Act) looks to be a game-changer and concern for smaller private practices in particular. With the proposed rule soon to be finalized,
1) Have any of you given serious thought to which pathway you will choose:
MIPS (Merit-Based Incentive Payment System), which based on how quality measures are scored may increase or decrease your reimbursement by 4-9% increasing from 2019-2022 on.
APM (Advanced alternative payment model). Seems challenging for most smaller groups to obtain.
2) Does anyone plan on paying a consulting firm to guide them through this? If so, who are you using and what are you paying?
MACRA (Medicare Access and CHIP reauthorization Act) looks to be a game-changer and concern for smaller private practices in particular. With the proposed rule soon to be finalized,
1) Have any of you given serious thought to which pathway you will choose:
MIPS (Merit-Based Incentive Payment System), which based on how quality measures are scored may increase or decrease your reimbursement by 4-9% increasing from 2019-2022 on.
APM (Advanced alternative payment model). Seems challenging for most smaller groups to obtain.
2) Does anyone plan on paying a consulting firm to guide them through this? If so, who are you using and what are you paying?
Comment